ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011+/- nivolumab (nivo) in patients (pts) with advanced cancers Meeting Abstract


Authors: Yap, T. A.; Burris, H. A.; Kummar, S.; Falchook, G. S.; Pachynski, R. K.; LoRusso, P.; Tykodi, S. S.; Gibney, G. T.; Gainor, J. F.; Rahma, O. E.; Seiwert, T. Y.; Meric-Bernstam, F.; Blum Murphy, M. A.; Keating Litton, J.; Diament Hooper, E. M.; Hirsch, H. A.; Harvey, C.; Clancy, M.; McClure, T.; Callahan, M. K.
Abstract Title: ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011+/- nivolumab (nivo) in patients (pts) with advanced cancers
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 137s
Language: English
ACCESSION: WOS:000442916001375
DOI: 10.1200/JCO.2018.36.15_suppl.3000
PROVIDER: wos
Notes: Meeting Abstract: 3000 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Margaret Kathleen Callahan
    199 Callahan